ACTICOR BIOTECH (FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

The Society for Cardiovascular Angiography & Interventions (SCAI) is pleased to announce the publication of the Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary ...

Study compares immediate post-discharge care requirements for respiratory syncytial virus (RSV), influenza, acute myocardial ...

The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offsite pharmacy and delivered as a ready-to-use unit dose.

Someone has a heart attack every 40 seconds in the U.S., with the majority being first heart attacks, as opposed to affecting ...

A widowmaker heart attack affects the left anterior descending (LAD) artery. Read on to learn the effects and likelihood of ...

A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex ...

Coronary artery bypass grafting (CABG) is a treatment option offered to a growing population of octogenarians, considering ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...